Dimension Therapeutics
BioNidum™: a bioinspired cell delivery system combining 3D-printing, materials science, and digital manufacturing to create implantable tissue-like therapies from cells
- Sector
- Biotech
- Headquarters
- Cambridge, MA
- Founded
- 2013
- Latest Form D
- $65M, Apr 2015
- Total capital
- $70M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $70M
- 2 Form D · last Apr 2015
- 138 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$65M
- Private capital raisedForm D · SEC · 1st filing$5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Allan J. FoxDirectorNamed in SEC Form D filings
- Annalisa JenkinsExecutive Officer, DirectorNamed in SEC Form D filings
- Benjamin AuspitzDirectorNamed in SEC Form D filings
- Donald HaydenDirectorNamed in SEC Form D filings
- Donald J. Hayden, Jr.DirectorNamed in SEC Form D filings
- Jay K. HachigianExecutive OfficerNamed in SEC Form D filings
Show all 8 people
- Rishi GuptaDirectorNamed in SEC Form D filings
- Thomas BeckExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 11- PendingUse Of Glucocorticoid Analogs To Enhance Recombinant Adeno-associated Virus YieldUSPTOApplication 16316426
- PendingMethods And Compositions For Treating Glycogen Storage DiseasesUSPTOApplication 62781380
- PendingUse Of Tonicifying Agents To Enhance Recombinant Adeno-associated Virus YieldUSPTOApplication PCTUS2017056588
Show all 11 patent records
- Use Of Glucocorticoid Analogs To Enhance Recombinant Adeno-associated Virus YieldSep 26, 2019 · Application 16316426Pending
- Methods And Compositions For Treating Glycogen Storage DiseasesApplication 62781380Pending
- Use Of Tonicifying Agents To Enhance Recombinant Adeno-associated Virus YieldApplication PCTUS2017056588Pending
- Use Of Glucocorticoid Analogs To Enhance Recombinant Adeno-associated Virus YieldApplication PCTUS2017041738Pending
- Scalable Method For Producing Transfection ReagentsApplication 62503660Pending
- Methods Of Heat Inactivation Of AdenovirusApplication PCTUS2017024545Pending
- Cell Culture Methods Involving Hdac Inhibitors Or Rep ProteinsApplication 62475112Pending
- Methods For Enhancing Clarification Yield Of Recombinant Adeno-associated VirusApplication 62474932Pending
- Use Of Tonicifying Agents To Enhance Recombinant Adeno-associated Virus YieldApplication 62408420Pending
- Use Of Glucocorticoid Analogs To Enhance Recombinant Adeno-associated Virus YieldApplication 62361098Pending
- Methods of Heat Inactivation of AdenovirusApplication 62314116Pending
Related companies, and why
- Elevation OncologySimilar federal contract value in Biotech · null in contracts
- NANOMATRONIX LLCSimilar federal contract value in Biotech · null in contracts
- Neon TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Progentos TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Arcturus BiotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Crossbow TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .